Anticoagulant
From Anvita Health Wiki
Contents |
More Specific Terms
- anisindione (Miradon)
- annexin A8; annexin-8; annexin VIII; vascular anticoagulant-beta; VAC-beta (ANXA8, ANX8)
- antithrombin
- apixaban
- bivalirudin (Angiomax)
- coagulation factor II autoantibody; prothrombin antibody
- coagulation factor V autoantibody
- coagulation factor VII autoantibody
- coagulation factor VIII alloantibody
- coagulation factor VIII autoantibody
- coagulation factor X autoantibody
- coumarin; chromen-2-onel cumarin; 1,2-benzopyrone; tonka bean camphor (Rattex)
- danaparoid (Orgaran)
- dicumarol
- fondaparinux (Arixtra)
- heparin
- heparinoid
- in-vitro anticoagulant
- protein C, activated
- protein-S
- rivaroxaban (Xarelto)
- thrombin inhibitor
- von Willebrand factor (VWF) autoantibody
- warfarin (Coumadin, Panwarfin)
Classification
- drugs
- autoantibodies that inhibit activity of a clotting factor ( in vitro coagulation tests fail to correct with addition of normal plasma)
- autoantibodies that enhance clearance of a clotting factor from circulation ( in vitro coagulation tests correct with addition of normal plasma)
- alloantibodies to factor VIII occurs in up to 20-25% of hemophiliacs transfused with factor VIII
More General Terms
Additional Terms
References
- Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- Prescriber's Letter 18(10): 2011 Detail-Document#: [1] Comparison of Oral Anticoagulants and Antiplatelets (subscription needed) [2]
- Prescriber's Letter 18(12): 2011 Comparison of Oral Antithrombotics Detail-Document#: [3] (subscription needed) [4] - National Guideline Clearinghouse Parenteral anticoagulants. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). ngc-guideline: [5]
